QT Imaging Receives Saudi FDA Clearance for Breast Acoustic CT Technology

Key Facts

In a move reflecting the expansion of advanced healthcare technologies in the region, QT Imaging Holdings announced that its innovative breast imaging technology has received regulatory clearance from the Saudi Food and Drug Authority (SFDA). According to reports, the company's Breast Acoustic CT scanner has been officially classified and cleared as a medical device in the Kingdom of Saudi Arabia. This clearance allows the company to market and deploy its radiation-free imaging technology within the Saudi market, significantly expanding its international regulatory footprint.

This approval comes at a time when healthcare investments in Saudi Arabia are witnessing substantial growth under Vision 2030, as the Kingdom seeks to localize advanced medical technologies. Compared to medical imaging peers such as GE HealthCare and Siemens Healthineers, QT Imaging focuses on acoustic-based technologies that provide a safe alternative to traditional imaging. Per market data, the entry of specialized medical device firms into the Saudi market is viewed as a positive catalyst for international revenue growth outside of the US domestic market.